Gwt-tud Gmbh

This phase 3 study tested whether adding the targeted drug polatuzumab vedotin to standard chemotherapy (R-ICE) helps people with diffuse large B-cell lymphoma that has come back or not responded to initial treatment. About 306 adults took part. The main goal was to see if the ne…

This study tested a combination of three drugs (pomalidomide, ixazomib, and dexamethasone) with or without a fourth drug (cyclophosphamide) in 66 adults with multiple myeloma that had come back or stopped responding to treatment. The goal was to see how well the treatment control…

This study tested a new treatment plan for people with advanced pancreatic cancer that has spread. It combined chemotherapy with drugs that change how genes work and boost the immune system. The goal was to see if this approach is safe and can help control the disease. 75 patient…